Wutah dodolan YoY sajrone 12 wulan kepungkur: NexImmune, Inc. (NEXI)

Logo perusahaan publik NexImmune Corporation (NEXI)

The rolling period YoY sales growth trajectory for NexImmune, Inc. (NEXI) shows a decline, as the 0.00 level represents the current value. Cost optimization is achieved by outsourcing all trials to external contractors. However, the potential of the AIM platform to develop anti-cancer agents is offset by a critical shortage of funds. Currently, business operations have virtually ceased, creating a real threat of delisting from the exchange.

Wutah pendapatan YoY sajrone 12 wulan kepungkur NexImmune (NEXI): kanggo periode 11.02.2024 - 20.02.2024

NexImmune (NEXI) - rincian metrik lan laporan keuangan

- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:NexImmune, Inc.
Sampel barang neximmune.com

Assessing stock reliability requires analyzing business scaling rates by comparing current annual revenue with the same period of the previous cycle. This calculation reveals the operational efficiency of NexImmune, Inc. (NEXI) in commercializing its artificial antigen-presenting cell platform, utilizing 12-month year-over-year revenue dynamics to determine how successfully the precise immune retraining technology is transforming into actual financial growth.

Pesaing NexImmune, Inc. (NEXI)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|Immix Biopharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALX Oncology (ALXO) - Wutah pendapatan taun lumaku|CUE: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku PDSB|sonnetbio.com (SONN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|MAIA Biotechnology Inc (MAIA) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur liminatuspharma.com|Wutah dodolan YoY sajrone rolas wulan kepungkur LVTX|Wutah pendapatan YoY sajrone 12 wulan kepungkur NXTC (NextCure, Inc.)|LPTX: Wutah dodolan taun lumaku|Wutah dodolan YoY sajrone rolas wulan kepungkur intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Wutah pendapatan taun lumaku|TOVX: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Gritstone bio - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Kineta Bio (KA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur